Engility wins position on $8bn US DoD contract

22 December 2017 (Last Updated January 5th, 2018 07:05)

Engility has secured a position on the US Department of Defense’s (DoD) Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) $8bn contract for developing chemical, biological, radiological and nuclear (CBRNE) defence systems.

Engility has secured a position on the US Department of Defense’s (DoD) Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) $8bn contract for developing chemical, biological, radiological and nuclear (CBRNE) defence systems.

The indefinite-delivery, indefinite-quantity contract covers the research and development of services related to CBRNE defence systems and equipment to the DoD.

The JPEO-CBD is responsible for managing and directing CBRNE defence systems from development through deployment and sustainment.

It is tasked with preventing adversary CBRNE weapon employment, identifying threats and hazards, and taking proactive measures.

“We’ll couple our systems engineering with a manufacturing capability to produce unique solutions to help solve the government’s most difficult CBRNE challenges.”

Engility Defense and Security Group senior vice-president Scott Whatmough said: “For decades, the DoD has relied on Engility for high-end CBRNE expertise, and this contract is a great opportunity to expand our relationship and deliver the latest capabilities.

“Through these contract task orders, we’ll couple our systems engineering expertise with a manufacturing capability to produce unique solutions to help solve the government’s most difficult CBRNE challenges.”

The contract has a ten-year base period and an option to extend the term by five years.

Engility is already serving the DoD on other contracts including the joint enterprise omnibus professional engineering and technical support (JE-OPETS) and joint enterprise contracted logistics and service support (JE-CLaSS).